Thomas P. Mechtler

1.4k total citations
33 papers, 1.0k citations indexed

About

Thomas P. Mechtler is a scholar working on Physiology, Epidemiology and Molecular Biology. According to data from OpenAlex, Thomas P. Mechtler has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 10 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Thomas P. Mechtler's work include Lysosomal Storage Disorders Research (19 papers), Trypanosoma species research and implications (6 papers) and Metabolism and Genetic Disorders (5 papers). Thomas P. Mechtler is often cited by papers focused on Lysosomal Storage Disorders Research (19 papers), Trypanosoma species research and implications (6 papers) and Metabolism and Genetic Disorders (5 papers). Thomas P. Mechtler collaborates with scholars based in Austria, United States and Germany. Thomas P. Mechtler's co-authors include David C. Kasper, Albina Nowak, Robert J. Desnick, K. Herkner, Berthold Streubel, Víctor R. De Jesús, Susanne Greber‐Platzer, Angelika Berger, Arnold Pollak and Armin Witt and has published in prestigious journals such as The Lancet, Clinical Chemistry and Chemical Science.

In The Last Decade

Thomas P. Mechtler

31 papers receiving 987 citations

Peers

Thomas P. Mechtler
Néstor Chamoles Argentina
Bryan Harris United States
Mamta Muranjan India
Ellen Crushell Ireland
Néji Tebib Tunisia
Lawrence Greed Australia
Pauli Vuorinen Finland
Sandra D.K. Kingma Netherlands
Valérie Furlan France
David G. Oelberg United States
Néstor Chamoles Argentina
Thomas P. Mechtler
Citations per year, relative to Thomas P. Mechtler Thomas P. Mechtler (= 1×) peers Néstor Chamoles

Countries citing papers authored by Thomas P. Mechtler

Since Specialization
Citations

This map shows the geographic impact of Thomas P. Mechtler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Mechtler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Mechtler more than expected).

Fields of papers citing papers by Thomas P. Mechtler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Mechtler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Mechtler. The network helps show where Thomas P. Mechtler may publish in the future.

Co-authorship network of co-authors of Thomas P. Mechtler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Mechtler. A scholar is included among the top collaborators of Thomas P. Mechtler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Mechtler. Thomas P. Mechtler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vinatzer, Ursula, Michael P. Lux, Petra Oliva, et al.. (2024). Biochemical and Genetic Testing of GAA in Over 30.000 Symptomatic Patients Suspected to Be Affected With Pompe Disease. Human Mutation. 2024(1). 6248437–6248437.
2.
Bekri, Soumeya, Annette Bley, Heather A. Brown, et al.. (2024). Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide. Molecular Genetics and Metabolism. 142(1). 108436–108436. 2 indexed citations
3.
Oliva, Petra, Markus Schwarz, Thomas P. Mechtler, et al.. (2023). Importance to include differential diagnostics for acid sphingomyelinase deficiency (ASMD) in patients suspected to have to Gaucher disease. Molecular Genetics and Metabolism. 139(1). 107563–107563. 4 indexed citations
4.
Oliva, Petra, Stefaan Sansen, Thomas P. Mechtler, et al.. (2019). Diagnostic strategy for females suspected of Fabry disease. Clinical Genetics. 97(4). 655–660. 21 indexed citations
5.
Nowak, Albina, Thomas P. Mechtler, David C. Kasper, & Robert J. Desnick. (2017). Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease. Molecular Genetics and Metabolism. 121(4). 320–324. 56 indexed citations
6.
Nowak, Albina, Thomas P. Mechtler, Thorsten Hornemann, et al.. (2017). Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease. Molecular Genetics and Metabolism. 123(2). 148–153. 79 indexed citations
7.
Nowak, Albina, Thomas P. Mechtler, Robert J. Desnick, & David C. Kasper. (2017). Plasma lyso-Gb3: a useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes. Molecular Genetics and Metabolism. 120(1-2). S103–S104. 5 indexed citations
8.
Nowak, Albina, Thomas P. Mechtler, Robert J. Desnick, & David C. Kasper. (2016). Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes. Molecular Genetics and Metabolism. 120(1-2). 57–61. 95 indexed citations
9.
Benkoe, Thomas, Thomas P. Mechtler, Mario Pones, et al.. (2014). The plasma activities of lysosomal enzymes in infants with necrotizing enterocolitis: New promising class of biomarkers?. Clinica Chimica Acta. 438. 279–283. 6 indexed citations
10.
Benkoe, Thomas, Thomas P. Mechtler, M. Weninger, et al.. (2014). Serum levels of interleukin-8 and gut-associated biomarkers in diagnosing necrotizing enterocolitis in preterm infants. Journal of Pediatric Surgery. 49(10). 1446–1451. 51 indexed citations
11.
Mechtler, Thomas P., et al.. (2014). MALDI Orbitrap mass spectrometry for fast and simplified analysis of novel street and designer drugs. Clinica Chimica Acta. 433. 254–258. 18 indexed citations
12.
Kasper, David C., Thomas P. Mechtler, Judith Rittenschober-Böhm, et al.. (2013). Molecular Detection of Late-Onset Neonatal Sepsis in Premature Infants Using Small Blood Volumes: Proof-of-Concept. Neonatology. 103(4). 268–273. 37 indexed citations
13.
Schulz, Stefan M., Thomas P. Mechtler, Susanne Greber‐Platzer, et al.. (2013). DNA methylation pattern ofCALCAin preterm neonates with bacterial sepsis as a putative epigenetic biomarker. Epigenetics. 8(12). 1261–1267. 33 indexed citations
14.
Mechtler, Thomas P., Rene Ratschmann, Víctor R. De Jesús, et al.. (2012). Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening. Journal of Chromatography B. 908. 9–17. 20 indexed citations
15.
Mechtler, Thomas P., et al.. (2012). Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine. Clinica Chimica Acta. 413(15-16). 1259–1264. 13 indexed citations
16.
Mechtler, Thomas P., et al.. (2012). Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. The Lancet. 379(9813). 335–341. 226 indexed citations
17.
Kasper, David C., Thomas P. Mechtler, Judith Rittenschober-Böhm, et al.. (2011). In utero exposure to Ureaplasma spp. is associated with increased rate of bronchopulmonary dysplasia and intraventricular hemorrhage in preterm infants. Journal of Perinatal Medicine. 39(3). 331–6. 61 indexed citations
18.
Kasper, David C., Rene Ratschmann, Thomas P. Mechtler, et al.. (2010). The National Austrian Newborn Screening Program – Eight years experience with mass spectrometry. Past, present, and future goals. Wiener klinische Wochenschrift. 122(21-22). 607–613. 51 indexed citations
19.
20.
Kasper, David C., Thomas P. Mechtler, Georg H. Reischer, et al.. (2010). The bacterial load of Ureaplasma parvum in amniotic fluid is correlated with an increased intrauterine inflammatory response. Diagnostic Microbiology and Infectious Disease. 67(2). 117–121. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Néstor Chamoles Breakdown of academic impact, for papers by Bryan Harris Breakdown of academic impact, for papers by Mamta Muranjan Breakdown of academic impact, for papers by Ellen Crushell Breakdown of academic impact, for papers by Néji Tebib Breakdown of academic impact, for papers by Lawrence Greed Breakdown of academic impact, for papers by Pauli Vuorinen Breakdown of academic impact, for papers by Sandra D.K. Kingma Breakdown of academic impact, for papers by Valérie Furlan Breakdown of academic impact, for papers by David G. Oelberg
Rankless by CCL
2026